דילוג לתוכן הראשי
xMedica

NCT06956014ClinicalTrials.gov

Efficacy and Safety of VER-01 in the Treatment of Participants With Chronic Painful Lumbosacral Radiculopathy

Multicenter, Double-blind, Randomized, Placebo-controlled Phase III Trial to Evaluate the Efficacy and Safety of the Full-spectrum Cannabis Extract VER-01 in Participants With Chronic Painful Lumbosacral Radiculopathy

מגייסמקבל משתתפים כעת, לפי רשומת המרשם.
יצירת קשר עם המחקר

בקצרה

The aim of the trial is to prove the efficacy and safety of VER-01 compared to placebo in patients with chronic painful lumbosacral radiculopathy (PLSR) for whom drug treatment is indicated and previous optimized treatments with non-opioid analgesics have not…

שלב 3דרושים 810 משתתפים43 אתריםמדינה אחת

קטגוריות

רשום במרשם אחד

מחקר יחיד יכול להיות רשום בכמה מרשמים. אנו מציגים אותו פעם אחת ומקשרים לכל רשומה שברשותנו.

מידע הניסוי מוצג כפי שפורסם על ידי המרשם, בשפת המקור שלו.

מתעניינים במחקר הזה?

התחברות או צרו חשבון כדי לרשום את התעניינותכם ולעקוב אחר המחקר הזה.

How this study is set up

The points below are drawn from the public registry record for this study. Each one cites the field or sentence it came from. A dash (—) means the record does not state something — not that it is missing or wrong. Many well-run studies, especially small ones, leave some of these blank.

  • Present: Registered before enrolment beganFirst posted 2025-05-02; recorded start 2026-09-22
  • Present: Has a defined primary outcomeA primary outcome measure is listed in the record
  • Present: The primary outcome states a time frameThe primary outcome measure records a time frame
  • Present: Participants are randomly assignedAllocation is recorded as randomised
  • Present: Has a comparison groupThe record lists a placebo or comparator arm, or more than one study arm
  • Present: Uses blinding (masking)A masking level is recorded in the record
  • Not stated: An ethics committee is not stated in the registry recordThis registry's ingested record has no ethics-committee field
  • Not stated: Regulatory oversight (such as an IND or IDE) is not stated in the registry recordThis registry's ingested record has no regulatory-authorisation field
  • Not stated: A data monitoring committee is not stated in the registry recordThis registry's ingested record has no data-monitoring-committee fieldA data monitoring committee is not required for many smaller studies, and its absence here is not unusual.
  • Present: No cost to participants is mentioned in the recordChecked the summary, description and eligibility text; no cost-to-participant phrase found
  • Present: Sponsor has 2 other studies in this databaseCounted from the lead sponsor named in the record (Vertanical GmbH)
  • Not stated: No posted results from this sponsor are in this database yetBased on the sponsor’s studies in this database
  • The record lists 1 condition.
  • Lead sponsor type recorded as: industry.
  • Intervention regulatory context: investigational, within a phased regulatory pathway.

Trial stature

Three independent measures of this study, described from its registry record — not a recommendation about it. A rigorous study by investigators nobody has heard of is better evidence than a weak study led by a famous one. How these are scored.

Methodological rigourSTRONG

A strong methodological design for a phase 3 study, judged from its ClinicalTrials.gov record.

How this score is built
  • Randomised allocation20/20

    Participants are randomly allocated between arms

  • Blinding20/20

    Quadruple-blind

  • Control arm13/15

    Placebo / sham control arm

  • Primary-outcome specificity10/10

    Named primary outcome with a defined time frame

  • Endpoint type3/10

    Surrogate or intermediate endpoint (conservative default)

  • Multi-centre0/8

    Single site, or site count not stated

  • Data monitoring committee0/7

    No data monitoring committee stated

  • Prospective registration5/5

    Registered before the study start date

  • Protocol / SAP posted0/5

    No protocol or SAP posted to the registry

ScaleMEDIUM

A medium-sized study: 810 participants (target), run at 43 sites.

How this score is built
  • Enrolment29/40

    810 participants (target)

  • Site count0/25

    Site count not stated in the record

  • Country count0/15

    Country count not stated in the record

  • Planned duration7/10

    Planned over about 24 months

  • Sponsor scale1/10

    Vertanical GmbH has led 3 trials in our corpus

Investigator standingUNKNOWN

We have no verifiable track record for the investigator named on this trial. That is common for early-career investigators and for records held outside ClinicalTrials.gov — it is not a negative signal.

How this score is built
  • Investigator standing0/100

    No investigator recorded in the registry for this trial

These describe the registry record only, and today we hold ClinicalTrials.gov data. Absent fields lower a score, and absence often reflects registration practice rather than study quality. A high-stature trial is not necessarily safer or a better choice for you — enrolling in a large definitive trial can mean a higher chance of receiving placebo, while a small early-phase study may be the only route to a new therapy.

תקציר

The aim of the trial is to prove the efficacy and safety of VER-01 compared to placebo in patients with chronic painful lumbosacral radiculopathy (PLSR) for whom drug treatment is indicated and previous optimized treatments with non-opioid analgesics have not led to sufficient pain relief or were unsuitable due to contraindications or intolerance.

מצבים רפואיים

  • Lumbosacral Radiculopathy

זכאות

זכאות
מיןהכול
גילאים18 Years – ללא מקסימום
מתנדבים בריאיםלא

זכאות כפי שנכתבה במרשם

Inclusion Criteria: * Participants ≥ 18 years of age, all sexes * Participant voluntarily provided written informed consent * Participant is willing and able to comply with scheduled visits, treatment plan, eDiary, and other trial-related procedures throughout trial participation Exclusion Criteria: * Pregnant or breastfeeding female patients * Known history of previous or current severe psychiatric disorder as per DSM-5 (e.g., schizophrenia, bipolar disorder, severe anxiety disorder, psychotic disorder, post-traumatic stress disorder), or currently taking antipsychotic medication * Cardiovascular event or clinically significant cardiac dysfunction (e.g., congestive heart failure, myocardial ischemia, arrhythmias, poorly controlled high blood pressure, congenital long QT syndrome) within 12 months or a cardiac disorder that, in the opinion of the investigator, would put the patient at risk of a clinically significant arrhythmia or myocardial infarction

זכאות במשפטים פשוטים

הקריטריונים של רשומה זו טרם פורקו למשפטים נפרדים. טקסט המרשם שלמעלה שלם והוא הגרסה המחייבת.

תכנון המחקר

תכנון המחקר
סוג המחקרהתערבותי
שלבשלב 3
הקצאהאקראי
מודל ההתערבותPARALLEL
מטרה ראשיתTREATMENT
הסתרהQUADRUPLE (4)
גיוסדרושים 810 משתתפים

נותן חסות ושותפים

  • Vertanical GmbH נותן חסות

זרועות והתערבויות

  • VER-01 Dose 1EXPERIMENTAL
  • VER-01 Dose 2EXPERIMENTAL
  • PlaceboPLACEBO_COMPARATOR

התערבויות

  • אחר Placebo

    Comparator without active ingredient

  • תרופה VER-01

    Standardized soft extract from Cannabis sativa DKJ127 L., cannabis flos (Cannabis flower), corresponding to 19 mg Δ9-Tetrahydrocannabinol (THC) per ml drug product

מדדי תוצאה

  1. מדד תוצאה ראשוני

    Efficacy based on pain reduction

    The primary endpoint is the absolute change in mean leg pain intensity in the index leg measured on an 11-point numerical rating scale (NRS) at Treatment Week 12 compared to Baseline.

    מסגרת זמן From Baseline to Treatment Week 12

תאריכים

תאריכים
תאריך התחלה22 בספטמבר 2026 (בפועל)
סיום ראשוני1 בספטמבר 2028 (משוער)
סיום1 בספטמבר 2028 (משוער)
פורסם לראשונה2 במאי 2025 (בפועל)
עודכן לאחרונה19 בנובמבר 2026
התוצאות פורסמולא צוין ברשומת המרשם
המצב אומת לאחרונהנובמבר 2026

בפועל פירושו שהאירוע התרחש. משוער פירושו שנותן החסות צופה אותו. שתי המשמעויות שונות זו מזו.

מיקומים

43 אתרים מגייסים

United States

United States
מתקןעירמדינה או אזורמצב
Central Texas Clinical Research, LLCAustinTexasמגייס
Boston Clinical TrialsBostonMassachusettsמגייס
Bradenton Research CenterBradentonFloridaמגייס
DFW Clinical TrialsCarrolltonTexasמגייס
Epic Medical Research - CarroltonCarrolltonTexasמגייס
Clinitiative - Clinical Trials of South Carolina - CharlestonCharlestonSouth Carolinaמגייס
Epic Medical Research - ChickashaChickashaOklahomaמגייס
Velocity Clinical Research - ClevelandClevelandOhioמגייס
Epic Medical Research - DeSotoDeSotoTexasמגייס
Mountain View Clinical ResearchDenverColoradoמגייס
Innovare Research Group IFriendswoodTexasמגייס
AGA Clinical TrialsHialeahFloridaמגייס
HD Research - Memorial Hermann VillageHoustonTexasמגייס
Perfizien Clinical Research LLCHoustonTexasמגייס
Synergy Groups Medical - Southeast HoustonHoustonTexasמגייס
Green Leaf Clinical TrialsJacksonvilleFloridaמגייס
R & H Clinical ResearchKatyTexasמגייס
Alliance for Multispecialty Research - KnoxvilleKnoxvilleTennesseeמגייס
Epic Clinical Research - LewisvilleLewisvilleTexasמגייס
Central Medical Research InstituteLong BeachCaliforniaמגייס
Tekton Research - LongmontLongmontColoradoמגייס
K2 Medical Research - Maitland IIMaitlandFloridaמגייס
Velocity Clinical Research - MedfordMedfordOregonמגייס
Alma Clinical ResearchMiamiFloridaמגייס
Floridian Research Institute LLC IMiamiFloridaמגייס
AMR MobileMobileAlabamaמגייס
Monroe Biomedical Research - MonroeMonroeNorth Carolinaמגייס
Alliance for Multispecialty Research - NorfolkNorfolkVirginiaמגייס
Conquest Research - Lake NonaOrlandoFloridaמגייס
Alfa Medical Research - Pembroke PinesPembroke PinesFloridaמגייס
Flourish Research - PhiladelphiaPlymouth MeetingPennsylvaniaמגייס
United Medical ResearchPort OrangeFloridaמגייס
Boeson ResearchProvoUtahמגייס
CenExel JBR - Salt Lake CitySalt Lake CityUtahמגייס
Elixia Clinical Research CollaborativeSpringfieldMassachusettsמגייס
Professional Health Care of PinellasSt. PetersburgFloridaמגייס
Velocity Clinical Research - SuffolkSuffolkVirginiaמגייס
Alliance for Multispecialty Research - Tempe ITempeArizonaמגייס
Alliance for Multispecialty Research - Wichita EastWichitaKansasמגייס
Grayline Research CenterWichita FallsTexasמגייס
Progressive Medicine of the Triad, LLCWinston-SalemNorth Carolinaמגייס
Conquest Research - Winter ParkWinter ParkFloridaמגייס
Vitalix ClinicalWorcesterMassachusettsמגייס

מסמכי המחקר

לא צורפו מסמכים ברשומת מרשם זו.

שינויים לאורך זמן

  1. 19 בנובמבר 2026

    אתר נוסף

    11 sites added (43 total)

    3243

  2. 2 בנובמבר 2026

    אתר נוסף

    9 sites added (32 total)

    2332

  3. 21 באוקטובר 2026

    אתר נוסף

    1 site added (23 total)

    2223

  4. 19 באוקטובר 2026

    אתר נוסף

    21 sites added (22 total)

    122

  5. 28 בספטמבר 2026

    המצב השתנה

    Status changed from Not yet recruiting to Recruiting

    NOT_YET_RECRUITINGRECRUITING

  6. 28 בספטמבר 2026

    אתר נוסף

    1 site added (1 total)

    01

  7. 28 בספטמבר 2026

    הגיוס נפתח

    Recruitment opened

    NOT_YET_RECRUITINGRECRUITING